Precision Medicine Approach Based on Molecular Alterations for Patients with Relapsed or Refractory Multiple Myeloma: Results from the MM-EP1 Study

SIMPLE SUMMARY: Personalized treatment for patients with relapsed or refractory multiple myeloma (r/r MM) remains an ongoing challenge, and there are no anti-myeloma therapies based on molecular abnormalities available. Identifying recurrent molecular abnormalities could allow for guiding patients t...

Descripción completa

Detalles Bibliográficos
Autores principales: Andreozzi, Fabio, Dragani, Matteo, Quivoron, Cyril, Le Bras, Fabien, Assi, Tarek, Danu, Alina, Belhadj, Karim, Lazarovici, Julien, Cotteret, Sophie, Bernard, Olivier A., Ribrag, Vincent, Michot, Jean-Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10001403/
https://www.ncbi.nlm.nih.gov/pubmed/36900299
http://dx.doi.org/10.3390/cancers15051508

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10001403/
https://www.ncbi.nlm.nih.gov/pubmed/36900299
http://dx.doi.org/10.3390/cancers15051508

Ejemplares similares